Page 30 - கிழக்கு வர்ஜீனியா மருத்துவ பள்ளி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Infectious disease specialist answers Johnson & Johnson vaccine questions By: Web Staff and last updated 2021-02-25 17:25:10-05 NORFOLK, Va. - The Johnson & Johnson COVID-19 vaccine has met requirements for emergency use authorization in the United States. If approved, it will become the U.S. s third vaccine against the virus, joining Pfizer and Moderna. News 3 spoke to Dr. Edward Oldfield, an infectious disease specialist at Eastern Virginia Medical School, about questions he frequently hears about this vaccine. What are your overall thoughts on the Johnson & Johnson vaccine, and how does it compare to the other two? I think it s definitely going to be approved, Oldfield told News 3. Overall, the protective efficacy is about 72 percent versus the Moderna and Pfizer were closer to 95 percent, but you have to remember the studies were done at very different times. I don t think you can directly compare these percentages and say one is obviously less effectiv

United statesEdward oldfieldEastern virginia medical schoolஒன்றுபட்டது மாநிலங்களில்எட்வர்ட் ஓல்ட்ஃபீல்ட்கிழக்கு வர்ஜீனியா மருத்துவ பள்ளி